352 related articles for article (PubMed ID: 1658308)
1. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
Cox BM; Chavkin C
Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
[No Abstract] [Full Text] [Related]
3. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
Takemori AE; Portoghese PS
Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
[TBL] [Abstract][Full Text] [Related]
4. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
6. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
[TBL] [Abstract][Full Text] [Related]
7. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
Porreca F; LoPresti D; Ward SJ
Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
[TBL] [Abstract][Full Text] [Related]
8. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
9. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
11. The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies.
Kaneto H; Takahashi M; Watanabe J
J Pharmacobiodyn; 1990 Jul; 13(7):448-53. PubMed ID: 1963196
[TBL] [Abstract][Full Text] [Related]
12. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
Jin WQ; Chen XJ; Chi ZQ
Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa.
Yamamoto LT; Horie S; Takayama H; Aimi N; Sakai S; Yano S; Shan J; Pang PK; Ponglux D; Watanabe K
Gen Pharmacol; 1999 Jul; 33(1):73-81. PubMed ID: 10428019
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
15. TENA, a selective kappa opioid receptor antagonist.
Portoghese PS; Takemori AE
Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
[TBL] [Abstract][Full Text] [Related]
16. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
17. A novel phencyclidine analog interacts selectively with mu opioid receptors.
Itzhak Y; Simon EJ
J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
[TBL] [Abstract][Full Text] [Related]
18. The opioid activity and receptor selectivity of fluorinated Leu5 enkephalin analogues in vitro and in vivo.
Watanabe J; Tokuyama S; Takahashi M; Kaneto H; Maeda M; Kawasaki K; Taguchi T; Kobayashi Y; Yamamoto Y; Shimokawa K
J Pharmacobiodyn; 1991 Feb; 14(2):101-5. PubMed ID: 1651391
[TBL] [Abstract][Full Text] [Related]
19. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
20. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
